- Home
- ABEO vs MVBF Comparison
ABEO vs MVBF Comparison
Compare ABEO & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABEO | MVBF |
|---|---|---|
| Founded | 1974 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.0M | 351.9M |
| IPO Year | 1980 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABEO | MVBF |
|---|---|---|
| Price | $4.80 | $28.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $18.20 | ★ $27.60 |
| AVG Volume (30 Days) | ★ 1.5M | 79.3K |
| Earning Date | 11-12-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 2.45% |
| EPS Growth | N/A | ★ 73.99 |
| EPS | 1.29 | ★ 2.45 |
| Revenue | $400,000.00 | ★ $167,853,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,590.36 | $14.06 |
| P/E Ratio | ★ $3.89 | $11.34 |
| Revenue Growth | N/A | ★ 18.75 |
| 52 Week Low | $3.93 | $15.59 |
| 52 Week High | $7.54 | $28.72 |
Technical Indicators
Market Signals| Indicator | ABEO | MVBF |
|---|---|---|
| Relative Strength Index (RSI) | 46.79 | 64.74 |
| Support Level | $4.53 | $26.52 |
| Resistance Level | $5.61 | $28.72 |
| Average True Range (ATR) | 0.25 | 0.73 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 27.44 | 86.03 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.